BofA Lifts Colgate-Palmolive (CL) Outlook as Company Begins Execution of 2030 Strategic Plan

Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best Long-Term Dividend Stocks to Invest in Right Now.

On February 23, BofA raised its price recommendation on Colgate-Palmolive Company (NYSE:CL) to $105 from $100. It maintained a Buy rating on the shares. The analyst said the company’s presentation at CAGNY highlighted key initiatives tied to its 2030 Strategic Plan. BofA raised its target to reflect stronger confidence in the company’s business momentum. The firm also pointed to Colgate’s focused action plan around innovation as a key driver of future growth. During the Q4 2025 earnings call, Chairman, CEO, and President Noel Wallace said the company delivered stronger-than-expected results in the fourth quarter. He noted that the outlook for 2026 would mark the beginning of Colgate’s new 2030 strategy.

Wallace said the company achieved growth across several financial measures in 2025. These included organic sales, net sales, gross profit, base business earnings per share, and free cash flow. This progress came despite weaker category growth, higher raw material costs, and increased tariff pressure. He outlined the company’s 2030 strategic framework, which focuses on five core priorities. He said Colgate plans to strengthen its global brands and accelerate innovation through scientific research. The company also aims to expand demand by improving its omnichannel capabilities.

Wallace added that Colgate will increase its use of digital tools, data, analytics, and AI. He said the company is also working to improve supply chain efficiency through predictive analytics and automation. He noted that Colgate has introduced a strategic growth and productivity program to support these efforts. He said the program will help drive organizational changes and provide funding to support the company’s long-term strategy.

Colgate-Palmolive Company (NYSE:CL) continues to position itself as a growth-focused business. The company operates across Oral Care, Personal Care, Home Care, and Pet Nutrition.

While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Best GARP Stocks to Buy According to Analysts and 14 Best Affordable Dividend Stocks to Buy According to Analysts

Disclosure: None.  Follow Insider Monkey on Google News.